AstraZeneca India inks LoI with Strand Life Sciences
India, Nov. 18 -- AstraZeneca India has signed a Letter of Intent (LOI) with Strand Life Sciences, a genomics research and diagnostics company and a subsidiary of Reliance Industries Limited, to explore opportunities to collaborate in healthcare in India.
The collaboration brings together AstraZeneca Pharma India and Strand Life Sciences in a healthcare-focused partnership.
The disclosure, dated November 17, 2026, clarifies that the execution of the LOI does not constitute a related party transaction. AstraZeneca Pharma India and Strand Life Sciences are not related parties under applicable corporate governance norms.
Praveen Rao Akkinepally, Country President & Managing Director, AstraZeneca Pharma India, said "The continued growth de...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.